Abstract
As early as 1920, Cullen [1] described adenomyosis as “endometriosis with predominantly presence of fibromuscular tissue,” and in 1921 Sampson [2] distinguished three types of adenomyosis. However, adenomyosis remained little known in the later decades and written only as an appendix in books on endometriosis, not knowing that adenomyosis has a great adverse impact on women’s health. For a long time, adenomyosis could only be diagnosed on histological specimens after hysterectomy in reproductive age women with heavy menstrual bleeding or pelvic pain [3]. Therefore the incidence rate in retrospective studies was seriously underestimated, and the prevalence rate varies due to the criteria used. Over the last 10 years, adenomyosis has become a condition diagnosed in young reproductive age women [4] because of the recent advancements in imaging techniques. Despite the new diagnostic tools, the awareness of the disease is still poor among the doctors with consensus on definition, and classification is still lacking [5]. Furthermore, adenomyosis is often associated with other gynecological conditions, such as endometriosis and fibroids. This chapter will discuss the clinical features and diagnosis of adenomyosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cullen TS. The distribution of adenomyomata containing uterine mucosa. Arch Surg. 1920;1:215–83.
Sampson J. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 1927;14:422–69.
Taran FA, et al. Clinical characteristics indicating adenomyosis at the time of hysterectomy: a retrospective study in 291 patients. Arch Gynecol Obstet. 2012;285(6):1571–6.
Pinzauti S, et al. Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: association with symptoms. Ultrasound Obstet Gynecol. 2015;46(6):730–6.
Van den Bosch T, Van Schoubroeck D. Ultrasound diagnosis of endometriosis and adenomyosis: state of the art. Best Pract Res Clin Obstet Gynaecol. 2018;51:16–24.
Abbott JA. Adenomyosis and abnormal uterine bleeding (AUB-A)-pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol. 2017;40:68–81.
Vannuccini S, Petraglia F. Recent advances in understanding and managing adenomyosis. F1000Res. 2019;8:F1000 Faculty Rev-283.
Vannuccini S, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online. 2017;35(5):592–601.
Garcia-Solares J, et al. Pathogenesis of uterine adenomyosis: invagination or metaplasia? Fertil Steril. 2018;109(3):371–9.
Parra-Herran C, Howitt BE. Uterine Mesenchymal tumors: update on classification, staging, and molecular features. Surg Pathol Clin. 2019;12(2):363–96.
Zaloudek CJ, Soslow RA, Mesenchymal tumors of the uterus., in Blaustein’s pathology of the female genital tract (6), Kurman RJ, . 2011, Springer Science, New-York, NY 453–528.
Nucci MR. Uterine mesenchymal tumors. In: Crum CP, Lee KR, editors. Diagnostic gynecology and obstetric pathology. 2nd ed. Philadelphia, PA: Saunders Elsevier; 2011. p. 582–639.
Garcia L, Isaacson K. Adenomyosis: review of the literature. J Minim Invasive Gynecol. 2011;18(4):428–37.
Taran FA, Stewart EA, Brucker S. Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy. Geburtshilfe Frauenheilkd. 2013;73(9):924–31.
Vercellini P, et al. Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):465–77.
Ryan GL, Stolpen A, Van Voorhis BJ. An unusual cause of adolescent dysmenorrhea. Obstet Gynecol. 2006;108(4):1017–22.
Parker JD, et al. Persistence of dysmenorrhea and nonmenstrual pain after optimal endometriosis surgery may indicate adenomyosis. Fertil Steril. 2006;86(3):711–5.
Templeman C, et al. Adenomyosis and endometriosis in the California teachers study. Fertil Steril. 2008;90(2):415–24.
Weiss G, et al. Adenomyosis a variant, not a disease? Evidence from hysterectomized menopausal women in the study of Women's health across the nation (SWAN). Fertil Steril. 2009;91(1):201–6.
Vercellini P, et al. Adenomyosis at hysterectomy: a study on frequency distribution and patient characteristics. Hum Reprod. 1995;10(5):1160–2.
Parazzini F, et al. Risk factors for adenomyosis. Hum Reprod. 1997;12(6):1275–9.
Panganamamula UR, et al. Is prior uterine surgery a risk factor for adenomyosis? Obstet Gynecol. 2004;104(5 Pt 1):1034–8.
Curtis KM, et al. Disruption of the endometrial-myometrial border during pregnancy as a risk factor for adenomyosis. Am J Obstet Gynecol. 2002;187(3):543–4.
Guo SW, The Pathogenesis of Adenomyosis vis-a-vis endometriosis. J Clin Med. 2020;9(2):485.
Bergholt T, et al. Prevalence and risk factors of adenomyosis at hysterectomy. Hum Reprod. 2001;16(11):2418–21.
Taran FA, et al. Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study. Hum Reprod. 2010;25(5):1177–82.
Parazzini F, et al. Risk factors for adenomyosis. Hum Reprod (Oxford, England). 1997;12(6):1279–5.
Lacheta J. Uterine adenomyosis: pathogenesis, diagnostics, symptomatology and treatment. Ceska Gynekol. 2019;84(3):240–6.
Wainer R. Smoking and ovarian fertility. Gynecol Obstet Fertil. 2001;29(12):881–7.
Van Voorhis BJ, et al. The effects of smoking on ovarian function and fertility during assisted reproduction cycles. Obstet Gynecol. 1996;88(5):785–91.
Yeniel O, et al. Adenomyosis: prevalence, risk factors, symptoms and clinical findings. Clin Exp Obstet Gynecol. 2007;34(3):163–7.
Li X, Liu X, Guo SW. Clinical profiles of 710 premenopausal women with adenomyosis who underwent hysterectomy. J Obstet Gynaecol Res. 2014;40(2):485–94.
Kissler S, et al. Duration of dysmenorrhoea and extent of adenomyosis visualised by magnetic resonance imaging. Eur J Obstet Gynecol Reprod Biol. 2008;137(2):204–9.
Harel Z. Dysmenorrhea in adolescents and young adults: from pathophysiology to pharmacological treatments and management strategies. Expert Opin Pharmacother. 2008;9(15):2661–72.
Quinn M. Uterine innervation in adenomyosis. J Obstet Gynaecol. 2007;27(3):287–91.
Leyendecker G, et al. Adenomyosis and endometriosis. Re-visiting their association and further insights into the mechanisms of auto-traumatisation. An MRI study. Arch Gynecol Obstet. 2015;291(4):917–32.
Naftalin J, et al. Is adenomyosis associated with menorrhagia? Hum Reprod. 2014;29(3):473–9.
Gordts S, Grimbizis G, Campo R. Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis. Fertil Steril. 2018;109(3):380–388.e1.
McCausland AM. Hysteroscopic myometrial biopsy: its use in diagnosing adenomyosis and its clinical application. Am J Obstet Gynecol. 1992;166(6 Pt 1):1619–26. discussion 1626-8
Munro MG, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3–13.
Pervez SN, Javed K. Adenomyosis among samples from hysterectomy due to abnormal uterine bleeding. J Ayub Med Coll Abbottabad. 2013;25(1–2):68–70.
Mobarakeh MD, Maghsudi A, Rashidi I. Adenomyosis among samples from hysterectomy due to abnormal uterine bleeding in Ahwaz, southern Iran. Adv Biomed Res. 2012;1:49.
Younes G, Tulandi T. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis. Fertil Steril. 2017;108(3):483–490.e3.
Salim R, et al. Adenomyosis reduces pregnancy rates in infertile women undergoing IVF. Reprod Biomed Online. 2012;25(3):273–7.
Vercellini P, et al. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum Reprod. 2014;29(5):964–77.
Peric H, Fraser IS. The symptomatology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):547–55.
Champaneria R, et al. Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy. Acta Obstet Gynecol Scand. 2010;89(11):1374–84.
Sofic A, et al. The significance of MRI evaluation of the uterine Junctional zone in the early diagnosis of Adenomyosis. Acta Inform Med. 2016;24(2):103–6.
Kishi Y, et al. Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification. Am J Obstet Gynecol. 2012;207(2):114.e1–7.
Grimbizis GF, Mikos T, Tarlatzis B. Uterus-sparing operative treatment for adenomyosis. Fertil Steril. 2014;101(2):472–87. e8
Bazot M, Darai E. Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis. Fertil Steril. 2018;109(3):389–97.
Babacan A, et al. CA 125 and other tumor markers in uterine leiomyomas and their association with lesion characteristics. Int J Clin Exp Med. 2014;7(4):1078–83.
Kil K, et al. Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma. Eur J Obstet Gynecol Reprod Biol. 2015;185:131–5.
El-Toukhy T, et al. Hysteroscopy in recurrent in-vitro fertilisation failure (TROPHY): a multicentre, randomised controlled trial. Lancet. 2016;387(10038):2614–21.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Dai, Y., Leng, J. (2021). The Clinical Features and Diagnosis of Adenomyosis. In: Xue, M., Leng, J., Wong, F. (eds) Adenomyosis. Springer, Singapore. https://doi.org/10.1007/978-981-33-4095-4_4
Download citation
DOI: https://doi.org/10.1007/978-981-33-4095-4_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-4094-7
Online ISBN: 978-981-33-4095-4
eBook Packages: MedicineMedicine (R0)